These contradictions can be attributed to the racial and genetic differences in the molecular pathogenesis of prostate cancer among the different races with Africans more likely to have TMPRSS2-ERG gene fusion through deletion [9, 12, 31]. Here, TMPRSS2 is linked to prostate cancer.